This past week, DeNovX conducted site visits, technology updates, and data collection with its strategic partners at the Advanced Photon Source at Argonne National Laboratory and at the Stanford Synchrotron Radiation Lightsource at SLAC National Accelerator Laboratory. DeNovX is developing a reproducible high throughput synchrotron powder X-ray diffraction workflow to support pharmaceutical development under a Phase II SBIR grant from the National Institutes of Health. The interdisciplinary team comprising chemists, physicists, engineers, and crystallographers has progressed through prototyping, reproducibility studies, and rigorous method qualification studies and is now demonstrating benefits that include rapid data collection requiring a fraction of the material of typical initial physical form screens. Stay tuned for exciting updates on this work at the Denver X-ray Conference and the Fall American Chemical Society Meeting (or just send an email to info@denovx.com).